New immune therapy for advanced melanoma offers hope for hard-to-treat disease
Source: NBC News, December 2022
An experimental treatment for advanced melanoma is poised to be the next major advance in cancer treatment, experts say.
The results of a phase 3 clinical trial published Wednesday in the New England Journal of Medicine showed that the treatment, which uses a superconcentrated boost of the person’s own immune cells, was more effective than the leading existing treatment at putting patients into remission.
The trial, conducted by researchers in the Netherlands, caps off a stunning decade of progress in the treatment of metastatic melanoma, a disease that a little more than a decade ago had a 5-year survival rate of just 5%.